Nanfang Hospital, Southern Medical University
Clinical trials sponsored by Nanfang Hospital, Southern Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a Four-Drug cocktail tame inoperable liver cancer? Results expected Oct 2026 (estimated)
- Blood pressure drug may boost cancer therapy in stomach cancer patients Results expected Oct 2026 (estimated)
- New combo therapy shows promise for tough esophageal cancer Results expected Nov 2026 (estimated)
- New ultrasound-guided technique may reduce stomach bleeding risk Results expected Nov 2026 (estimated)
- AI reads your social media to boost breast cancer mental health Results expected Nov 2026 (estimated)
-
Can a peptide drug shield the hearts of ICU patients?
Disease control CompletedResearchers are testing whether cardiomyopeptidin, an intravenous drug, can protect the heart muscle of ICU patients who have signs of cardiac injury but no diagnosed heart disease. The trial enrolls 234 adults with high troponin levels during their ICU stay. Participants receive…
Phase 4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Botox and PRP: a surprising new hope for hair loss?
Disease control CompletedThis study is testing whether combining platelet-rich plasma (PRP) with Botox injections works better than PRP alone for treating androgenetic alopecia (common pattern baldness). About 76 adults aged 18 to 60 with mild to moderate hair loss will receive either the combo treatment…
Phase 2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a new opioid dosing strategy ease ICU pain without ventilators?
Disease control CompletedThis trial compares three painkillers, hydromorphone, fentanyl, and butorphanol, given intravenously to ICU patients who are not on mechanical ventilation. The goal is to find the best dose of hydromorphone that achieves effective pain control while monitoring side effects like l…
Phase 4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Nighttime dialysis matches daytime in cleaning blood, study finds
Disease control CompletedThis study compared two types of home dialysis for people with end-stage kidney disease: nighttime automated dialysis (APD) and daytime manual dialysis (CAPD). 137 non-diabetic adults tried each method for 12 weeks. The goal was to see if nighttime dialysis was as good as daytime…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Stomach bacteria transplant shows promise for indigestion relief
Disease control CompletedThis study tested whether transplanting specific stomach bacteria (probiotics) could relieve symptoms of functional dyspepsia, a common digestive disorder. 74 adults with indigestion but no H. pylori infection received either the probiotic or a placebo. The main goal was to see i…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Liver cancer showdown: which combo causes less harm?
Disease control CompletedThis study looked at 562 people with advanced liver cancer to compare two treatment combinations: one using HAIC (chemotherapy directly into the liver) plus immunotherapy and targeted drugs, and the other using TACE (a procedure that blocks blood flow to the tumor) plus the same …
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Blood test ratio may speed up detection of dangerous lung clots
Diagnosis CompletedThis study looks at whether the ratio of two common blood test results (APTT and fibrinogen) can help diagnose pulmonary embolism, a serious condition where a blood clot blocks an artery in the lung. Researchers will compare this ratio in 1,000 patients who are suspected of havin…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Simple urine test could show if lung cancer immunotherapy is working
Knowledge-focused CompletedThis completed study looked at 150 people with advanced non-small cell lung cancer to see if proteins and metabolites in blood and urine could help monitor how well immunotherapy is working. Researchers used mass spectrometry to measure these markers before, during, and after tre…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Scientists use gut bacteria to predict cancer treatment success
Knowledge-focused CompletedThis study looked at 60 people with advanced rectal cancer to see if the bacteria in their gut and mouth could predict how well they respond to chemotherapy and radiation before surgery. Researchers collected stool and saliva samples before treatment and used machine learning to …
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Rare stomach cancer studied in 400 patients – no new treatment yet
Knowledge-focused CompletedThis study looked back at medical records of 400 people with a rare type of stomach cancer called GEN-FGML. The goal was to describe the different subtypes, how they were treated, and what happened to patients over time. No new drug or treatment was tested; instead, researchers h…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Can a wearable sensor accurately track blood sugar in the ICU?
Knowledge-focused CompletedThis study looked at how well a continuous glucose monitor (CGM) works in critically ill patients with high blood sugar. Researchers placed a small sensor on the skin of 55 ICU patients to measure glucose every 5 minutes for up to 7 days. They compared these readings to standard …
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC